drugset / Trial / NCT02153866

The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine

NCT02153866

RandomizedFactorialOpen-labelPrevention

Summary

Nowadays these are some vaccines being vaccinated simultaneously, and a doubt is aroused if the safety and immunogenicity are same between inoculating several vaccines simultaneously and inoculating individually. So we carry out this study. The purpose of this study is to evaluate the difference of safety and immunogenicity on vaccinating rotavirus vaccine simultaneously with measles-rubella vaccine(MR) or measles-mumps-rubella vaccine(MMR) compared to vaccinating rotavirus vaccine, MR or MMR individually.

Timeline

Start
2013-12
Primary completion
2014-05
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Measles-Mumps-Rubella Vaccine Vaccine 0.5 ml Subcutaneous
Subject Measles-Rubella vaccine Vaccine 0.5 ml Subcutaneous
Subject Rotarix Vaccine 3 ml Oral

Indications